Može li taj tajanstveni organ koji nestaje sadržavati ključ dugovječnosti?

Gregory Fahy, a cryobiologist known for his unconventional approach to aging, took a bold step in 1996 when he convinced his doctor to prescribe a month's worth of growth hormone. His goal was ambitious: to regrow his thymus, an immune organ that diminishes with age. Inspired by a rat study, Fahy believed that restoring the thymus could lead to a longer, healthier life. MRI scans showed that his thymic mass nearly doubled, though whether this translated to improved vitality remained unclear. Fahy, now chief scientific officer at Intervene Immune in Torrance, California, has transformed his personal experiment into clinical trials. This shift reflects a broader surge in thymus research. Over the past three years, the field has expanded rapidly, driven by findings linking thymus health to overall well-being. Recent studies suggest that declining thymic function correlates with increased mortality risks. These discoveries have sparked investor interest, with companies like TECregen in Basel raising substantial funds to explore thymus regeneration as a potential anti-aging therapy. Zag Bio, based in Cambridge, Massachusetts, recently secured $80 million in funding to pursue similar goals. Venture capitalists and pharmaceutical firms are increasingly engaging with scientists such as Fahy, signaling growing confidence in the field. Marcel van den Brink, a leading figure in thymus research at City of Hope, notes that the field has gained serious attention, contrasting with earlier skepticism. He recalls being dismissed for his work but now sees renewed interest and collaboration. Historically, the thymus was considered a vestigial organ. Researchers once speculated it played a role in bird eggshell formation but deemed it insignificant in mammals. Peter Medawar, a Nobel laureate, famously described the thymus as an evolutionary accident. However, these views have been challenged. Immunologist Jacques Miller's groundbreaking work in the 1960s revealed the thymus's critical role in generating T cells, essential for fighting infections and cancer. Without a functioning thymus, infants suffer severe immune deficiencies, highlighting the organ's vital role. In humans, the thymus undergoes dramatic changes. By adulthood, much of the organ transforms into fat, reducing T-cell production. This decline contributes to weakened immunity and higher disease susceptibility. As people age, the consequences of thymus atrophy become more pronounced, prompting renewed scientific inquiry into ways to reverse or mitigate this process. Researchers are exploring various avenues, including growth hormones and targeted therapies, to restore thymic function and potentially extend healthy lifespan. The implications of thymus research extend beyond aging. A robust immune system is crucial for preventing diseases, including cancer. Scientists argue that maintaining thymus health could offer protective benefits against multiple conditions. While the path to effective treatments remains complex, the increasing investment and collaborative efforts among researchers and investors suggest a promising future. As the field continues to evolve, the thymus, once overlooked, may soon play a central role in understanding and combating the effects of aging.